Credential Qtrade Securities’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-20,661
Closed -$472K – 357
2022
Q1
$472K Buy
20,661
+1,133
+6% +$27.7K 0.03% 191
2021
Q4
$540K Sell
19,528
-1,279
-6% -$34.2K 0.04% 184
2021
Q3
$580K Sell
20,807
-216
-1% -$6.13K 0.05% 165
2021
Q2
$617K Buy
21,023
+741
+4% +$22.4K 0.05% 164
2021
Q1
$643K Buy
20,282
+919
+5% +$27K 0.06% 136
2020
Q4
$402K Buy
19,363
+7,858
+68% +$147K 0.04% 148
2020
Q3
$179K Buy
11,505
+1,917
+20% +$33K 0.02% 197
2020
Q2
$175K Buy
+9,588
New +$169K 0.02% 182

Other funds holding BHC

Credential Qtrade Securities's BHC Position: Q2 2022 in Review

Credential Qtrade Securities sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 20,661 shares — an estimated $472K sold.

Credential Qtrade Securities first reported a position in BHC in Q2 2020 and held it in 8 quarters. The position peaked at $643K in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Credential Qtrade Securities reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Credential Qtrade Securities sold 20,661 Bausch Health shares in Q2 2022, an estimated $472K.
  • Credential Qtrade Securities first reported a position in Bausch Health in Q2 2020 and held it in 8 quarters.
  • Credential Qtrade Securities's Bausch Health position peaked at $643K in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Credential Qtrade Securities's 13F filing for Q2 2022, filed 21 Jul 2025.